Colchicine for Recurrent Pericarditis 2 - CORP-2


Recurrent pericarditis is one of the most common and troublesome complications of acute pericarditis, occurring in 10-50% of patients with pericarditis. Colchicine has been shown to be promising for the secondary prevention of recurrent pericarditis in the CORE (recurrent pericarditis), COPE (acute pericarditis) open-label studies, and the CORP (first recurrent pericarditis) trials.

The current trial sought to compare the safety and efficacy of colchicine as compared with placebo...